Geir Brathen
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Four decades of ALS care: a retrospective study of epidemiology, clinical course and changes in management.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: February 12, 2026
Genomic analyses reveal new insights into Alzheimer's disease.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 04, 2025
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways.
Journal: Molecular neurodegeneration
Published: November 26, 2024
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's disease.
Journal: Brain communications
Published: October 11, 2024
Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway - prevalence, ancestry, clinical characteristics and sociodemographic status.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 24, 2024
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.
Journal: American journal of human genetics
Published: January 02, 2024
Alcohol use among NTNU students 2007-19.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: December 13, 2023
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Journal: Alzheimer's research & therapy
Published: October 27, 2023
Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis.
Journal: Brain communications
Published: September 21, 2023
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.
Journal: Nature communications
Published: August 09, 2023
Last Updated: 09/26/2026